Timber Pharmaceuticals Insider ownership
What is the Insider ownership of Timber Pharmaceuticals?
The Insider ownership of Timber Pharmaceuticals, Inc. is 5.76%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NYSE compared to Timber Pharmaceuticals
What does Timber Pharmaceuticals do?
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.
Companies with insider ownership similar to Timber Pharmaceuticals
- Oasis Petroleum has Insider ownership of 5.75%
- Oasis Petroleum has Insider ownership of 5.75%
- Construction Partners Inc has Insider ownership of 5.75%
- Aspen Aerogels has Insider ownership of 5.75%
- GoldMining has Insider ownership of 5.75%
- Toray Industries has Insider ownership of 5.76%
- Timber Pharmaceuticals has Insider ownership of 5.76%
- Murphy Oil has Insider ownership of 5.76%
- Europcar Mobility S.A has Insider ownership of 5.76%
- Bright Health has Insider ownership of 5.77%
- China Industrial Securities International has Insider ownership of 5.77%
- Repare Therapeutics has Insider ownership of 5.77%
- First Business Services Inc has Insider ownership of 5.77%